STOCK TITAN

Actuate Therapeutics (ACTU) CEO RSUs Vest, 120,521 Shares Withheld for Taxes

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Actuate Therapeutics, Inc. reported equity compensation activity for President, CEO and Director Daniel M. Schmitt on August 14, 2026. A block of 272,056 restricted stock units vested and settled into the same number of common shares, consistent with prior grants. To cover federal and state tax withholding on this settlement, 120,521 shares of common stock were withheld by the company at a per-share value of $1.01. Following these transactions, Schmitt is also shown as trustee for several irrevocable family trusts, including one holding 564,071 common shares and others each holding 22,223 shares, which are reported as indirect ownership.

Positive

  • None.

Negative

  • None.
Insider SCHMITT DANIEL M
Role President, CEO and Director
Type Security Shares Price Value
Exercise Restricted Stock Units F4, F5 272,056 $0.00 $0.00
Exercise Common Stock F3, F4 272,056 $0.00 $0.00
Tax Withholding Common Stock F1, F2 120,521 $1.01 $122K
holding Common Stock F6 -- -- --
holding Common Stock F7 -- -- --
holding Common Stock F8 -- -- --
holding Common Stock F9 -- -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 301,716 shares (Direct); Common Stock — 564,071 shares (Indirect, By The Schmitt Family Irrevocable Trust, dated December 31, 2019); Common Stock — 22,223 shares (Indirect, By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019); Common Stock — 22,223 shares (Indirect, By The Anna Schmitt Irrevocable Trust, dated December 31, 2019); Common Stock — 22,223 shares (Indirect, By The Edward Schmitt Irrevocable Trust, dated December 31, 2019)
Footnotes (9)
  1. F1. Represents 120,521 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units ("RSUs").
  2. F2. Represents the closing price of Issuer's common stock on August 14, 2026.
  3. F3. Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs, which number excludes the withholding of 120,521 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1).
  4. F4. Each restricted stock unit represents a contingent right to receive one share of common stock.
  5. F5. 544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vested on August 14, 2026.
  6. F6. Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
  7. F7. Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
  8. F8. Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
  9. F9. Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
RSUs vested and settled 272,056 shares RSUs converting into common stock on August 14, 2026
Shares withheld for taxes 120,521 shares Common stock withheld to satisfy federal and state tax withholding on RSU settlement
Per-share value for tax withholding $1.01 per share Closing price of common stock on August 14, 2026 used for tax withholding
Initial RSU grant at IPO 544,111 RSUs RSUs granted to Daniel Schmitt upon IPO closing on August 14, 2024
Family trust holdings 564,071 shares Common shares held by The Schmitt Family Irrevocable Trust, reported as indirect ownership
Individual child trust holdings 22,223 shares Common shares held by each of the Andrew, Anna, and Edward Schmitt Irrevocable Trusts
Restricted Stock Units financial
"Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
withholding taxes financial
"shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed"
Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.
irrevocable trust financial
"Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
initial public offering financial
"restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Code F financial
"transaction code F indicates payment of tax liability by delivering or withholding securities"

FAQ

What equity award activity did ACTU report for CEO Daniel Schmitt on this Form 4?

ACTU reported that 272,056 restricted stock units vested and settled into common stock for CEO Daniel Schmitt on August 14, 2026, reflecting the scheduled settlement of previously granted RSUs tied to the company’s initial public offering.

How many ACTU shares were withheld for taxes in Daniel Schmitt’s August 2026 Form 4?

The Form 4 states that 120,521 shares of Actuate Therapeutics common stock were withheld to satisfy federal and state withholding taxes owed upon RSU settlement, using the $1.01 closing share price on August 14, 2026 as the valuation basis.

What RSU grant history does the ACTU Form 4 disclose for Daniel Schmitt?

The filing notes that 544,111 restricted stock units were granted to Daniel Schmitt upon Actuate’s IPO closing on August 14, 2024; 272,055 RSUs vested on August 14, 2025 and 272,056 RSUs vested on August 14, 2026, aligning with a two-year vesting schedule.

What indirect ACTU share holdings for Daniel Schmitt are reported via family trusts?

The Form 4 reports indirect ownership through several irrevocable trusts, including 564,071 shares held by The Schmitt Family Irrevocable Trust and 22,223 shares each held by the Andrew, Anna, and Edward Schmitt Irrevocable Trusts, with Daniel Schmitt serving as trustee of these entities.

Was the ACTU CEO’s August 2026 transaction described as a market sale or tax withholding?

The Form 4 codes the transaction as Code F and explains that 120,521 shares were withheld by Actuate Therapeutics to pay federal and state withholding taxes on RSU settlement, rather than being described as an open-market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SCHMITT DANIEL M

(Last)(First)(Middle)
C/O ACTUATE THERAPEUTICS, INC.
1751 RIVER RUN, SUITE 400

(Street)
FORT WORTH TEXAS 76107

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ACTUATE THERAPEUTICS, INC. [ ACTU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President, CEO and Director
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/14/2026M272,056(3)A$0(4)422,237(3)D
Common Stock08/14/2026F120,521(1)D$1.01(2)301,716(1)D
Common Stock564,071IBy The Schmitt Family Irrevocable Trust, dated December 31, 2019(6)
Common Stock22,223IBy The Andrew Schmitt Irrevocable Trust, dated December 31, 2019(7)
Common Stock22,223IBy The Anna Schmitt Irrevocable Trust, dated December 31, 2019(8)
Common Stock22,223IBy The Edward Schmitt Irrevocable Trust, dated December 31, 2019(9)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(4)08/14/2026M272,056 (5) (5)Common Stock272,056$0(4)0D
Explanation of Responses:
1. Represents 120,521 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units ("RSUs").
2. Represents the closing price of Issuer's common stock on August 14, 2026.
3. Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs, which number excludes the withholding of 120,521 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1).
4. Each restricted stock unit represents a contingent right to receive one share of common stock.
5. 544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vested on August 14, 2026.
6. Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
7. Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
8. Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
9. Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
/s/ Paul Lytle, Attorney-in-Fact08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)